Hannah Saul

Hannah Saul is an experienced leader in policy and patient advocacy, currently serving as the Director of Policy and Patient Advocacy Group Engagement at Hansa Biopharma since July 2023. From January 2018 to July 2023, Hannah held the position of Senior Director, Global Oncology Patient Affairs Lead at AstraZeneca, where a patient-centric approach was fostered through collaboration with the patient advocacy community. Prior roles include Global Director of Policy and Advocacy for Respiratory Disease at AstraZeneca, Associate Director of Patient Advocacy for Europe, the Middle East, and Africa at Celgene, and International Public Policy Manager for Oncology at Roche. Hannah has also contributed as Government and Industry Affairs Manager at Bayer Schering Pharma, Policy and Public Affairs Manager at Cancerbackup, and Parliamentary and Campaigns Manager at Action for Blind People. An early career included positions at bp and the House of Commons as a Research Assistant. Hannah holds a Bachelor's degree in British Politics and Legislative Studies from the University of Hull.